Skip to content
Walpar Nutritions logo

Walpar Nutritions

WALPAR NSE
₹25.00 No trade today
View as Markdown
MCP
Close 28 Oct 2026 ₹25.00 −20.90 −45.5% since 10 Nov 2025
Start ₹45.90

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures as of · TTM

ROCE
14.80%
Debt to Equity
0.89
EPS (TTM)
—
Book Value
₹20.13
Market Cap
—
P/E (TTM)
—
P/B
1.24
ROE
13.90%
Dividend Yield
0.00%
EBITDA
₹6.90 Cr
52W High
₹50.60
52W Low
₹21.25
Volume
0

Peer Comparison

Healthcare › Pharmaceuticals

Walpar Nutritions peer comparison
Sun Pharma
₹1,773.4038.81₹4,29,049 Cr4.770.90%16.00%20.50%₹61,631 Cr₹10,987 Cr
Divis Laboratories
₹10,037.5091.10₹2,65,269 Cr15.900.30%16.50%22.00%₹11,230 Cr₹2,925 Cr
Torrent Pharmaceuticals
₹4,738.5078.61₹1,77,061 Cr9.810.82%27.40%15.20%₹17,400 Cr₹2,099 Cr
Zydus Life Science
₹1,188.1026.44₹1,25,446 Cr4.370.08%21.20%21.10%₹28,592 Cr₹4,593 Cr
Laurus Labs
₹2,323.80114.81₹1,25,228 Cr20.720.04%18.30%17.80%₹7,270 Cr₹1,090 Cr
Dr Reddys Laboratories
₹1,374.0035.59₹1,14,543 Cr2.960.58%11.20%13.00%₹33,228 Cr₹3,184 Cr
Cipla
₹1,402.0033.59₹1,12,454 Cr3.200.93%11.60%15.50%₹28,324 Cr₹3,356 Cr
Walpar Nutritions (this company)
₹25.00—₹23 Cr1.240.00%13.90%14.80%——
Median 8 companies₹1,587.7038.81₹1,25,337 Cr4.570.44%16.25%16.65%₹28,324 Cr₹3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Key Insights

No strengths listed

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 13.7% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1072
OscillatorsBullish072
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
42.65
Neutral
MACD (12,26,9)
−0.56
Bullish
SMA (50)
27.61
Bearish
SMA (200)
39.89
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+66.97%
3Y+30.87%
1Y+9.77%

Net profit

Net profit growth by window
5Y+82.06%
3Y+54.72%
1Y+7.53%

Operating cash flow

Operating cash flow growth by window
5YTurned positive
3Y+18.49%
1Y−54.93%

Operating margin· change in pp

Operating margin growth by window
5Y+0.87 pp
3Y−1.48 pp
1Y+0.48 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹6.07 Cr
Mar 2022₹26.76 Cr
Mar 2023₹35.14 Cr
Mar 2024₹62.52 Cr
Mar 2025₹71.76 Cr
Mar 2026₹78.77 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹0.15 Cr
Mar 2022₹0.36 Cr
Mar 2023₹0.81 Cr
Mar 2024₹1.94 Cr
Mar 2025₹2.79 Cr
Mar 2026₹3.00 Cr

Half-yearly Results

₹ Cr
WALPAR half-yearly results, ₹ crore
Particulars Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
13.98
13.98
12.78
16.52
18.62
31.14
31.38
32.53
39.24
36.49
42.3
Expenses
13.47
13.47
12.27
15.52
16.12
29.15
28.62
29.89
36.16
33.55
38.58
Operating Profit
0.51
0.51
0.51
1
2.5
1.99
2.76
2.64
3.08
2.94
3.72
OPM %
3.65%
3.65%
3.99%
6.05%
13.43%
6.39%
8.8%
8.12%
7.85%
8.06%
8.79%
Other Income
0.04
0.04
−0.02
0.05
0.27
0.06
0.16
0.31
−0.04
0.13
0.13
Interest
0.25
0.25
0.24
0.44
0.36
0.33
0.34
0.26
0.03
0.3
0.5
Depreciation
0.13
0.13
0.15
0.84
1.07
0.92
0.89
0.88
0.94
1
1.02
PBT
0.17
0.17
0.1
−0.23
1.34
0.8
1.69
1.81
2.07
1.77
2.33
Tax %
29.41%
29.41%
−130%
39.13%
15.67%
20%
23.08%
22.1%
32.85%
15.25%
27.04%
Net Profit
0.12
0.12
0.24
−0.33
1.14
0.65
1.29
1.41
1.39
1.5
1.5
EPS (₹)
0.19
0.14
0.27
−0.42
1.07
0.43
1.26
1.37
1.11
1.37
1.26

Profit & Loss

₹ Cr
WALPAR profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
6.07
26.76
35.14
62.52
71.76
78.77
Expenses
5.61
25.74
31.65
57.77
66.04
72.11
Operating Profit
0.46
1.02
3.49
4.75
5.72
6.66
OPM %
7.58%
3.81%
9.93%
7.6%
7.97%
8.45%
Other Income
0
0.02
0.32
0.22
0.27
0.26
Interest
0.18
0.48
0.79
0.67
0.29
0.8
Depreciation
0.12
0.28
1.91
1.81
1.82
2.02
PBT
0.16
0.28
1.11
2.49
3.88
4.1
Tax %
6.25%
−32.14%
27.03%
22.09%
27.84%
21.71%
Net Profit
0.15
0.36
0.81
1.94
2.79
3
EPS (₹)
0.22
0.42
0.65
1.68
2.47
2.63
Div. Payout %
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
WALPAR balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.34
4.54
4.54
4.7
9.39
9.39
Reserves
1.44
6.45
7.17
9.49
7.17
9.51
Borrowings
7.49
7.25
10.3
8.3
7.85
16.77
Other Liabilities
5.73
9.85
12.29
14.67
22.98
30.4
Total Liabilities
18
28.09
34.3
37.16
47.39
66.07
Fixed Assets
1.7
2.01
10.13
10.2
10.65
12.21
CWIP
1.22
4.48
0.02
0.02
0.03
0.05
Investments
0
0.49
0.02
1.88
1.88
2.88
Other Assets
15.08
21.11
24.13
25.06
34.83
50.93
Total Assets
18
28.09
34.3
37.16
47.39
66.07

Cash Flow

₹ Cr
WALPAR cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.31
−1.08
1.1
5.35
4.06
1.83
Investing
−2.02
−6.14
−3.44
−3.61
−2.3
−6.57
Financing
2.95
6.71
2.42
−1.77
−0.68
8.08
Net Cash Flow
0.62
−0.51
0.07
−0.03
1.08
3.34
Free Cash Flow
−2.17
−4.92
−4.14
3.48
1.78
−1.76
CFO/OP
−67
−99
34
116
82
41

Ratios

WALPAR financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
431
124
130
78.46
108
109
Inventory Days
369
103
129
67.15
67.85
93.74
Days Payable
455
135
144
72.94
109
136
Cash Conversion Cycle
344
92.41
114
72.67
67.07
66.09
Working Capital Days
316
61.65
87.87
43.55
42.17
40.68
ROCE %
—
4.85%
8.78%
12.75%
16.08%
14.84%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Walpar Nutritions insights

56 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 68.99%
  • Public 23.60%
  • Others 7.41%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Walpar Nutritions

What does Walpar Nutritions Ltd do?
Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.
Where is Walpar Nutritions Ltd (WALPAR) listed?
Walpar Nutritions Ltd trades as WALPAR on the NSE.
Which sector does Walpar Nutritions Ltd belong to?
Walpar Nutritions Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the 52-week high and low of Walpar Nutritions Ltd?
Over the last 52 weeks Walpar Nutritions Ltd has traded between ₹21.25 and ₹50.6 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Walpar Nutritions Ltd?
Walpar Nutritions Ltd reported a return on equity of 13.90%. Its debt-to-equity ratio is 0.89.

Company Information

Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.

Website walparnutritions.com
Listed 13 Jul 2021
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/WALPAR.md for Walpar Nutritions Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month